FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:FOXP1-ARMC8

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: FOXP1-ARMC8
FusionPDB ID: 31190
FusionGDB2.0 ID: 31190
HgeneTgene
Gene symbol

FOXP1

ARMC8

Gene ID

27086

25852

Gene nameforkhead box P1armadillo repeat containing 8
Synonyms12CC4|HSPC215|MFH|QRF1|hFKH1BGID5|HSPC056|S863-2|VID28
Cytomap

3p13

3q22.3

Type of geneprotein-codingprotein-coding
Descriptionforkhead box protein P1fork head-related protein like Bglutamine-rich factor 1mac-1-regulated forkheadarmadillo repeat-containing protein 8GID complex subunit 5, VID28 homolog
Modification date2020032920200313
UniProtAcc

Q9H334

Main function of 5'-partner protein: FUNCTION: Transcriptional repressor (PubMed:18347093, PubMed:26647308). Can act with CTBP1 to synergistically repress transcription but CTPBP1 is not essential (By similarity). Plays an important role in the specification and differentiation of lung epithelium. Acts cooperatively with FOXP4 to regulate lung secretory epithelial cell fate and regeneration by restricting the goblet cell lineage program; the function may involve regulation of AGR2. Essential transcriptional regulator of B-cell development. Involved in regulation of cardiac muscle cell proliferation. Involved in the columnar organization of spinal motor neurons. Promotes the formation of the lateral motor neuron column (LMC) and the preganglionic motor column (PGC) and is required for respective appropriate motor axon projections. The segment-appropriate generation of spinal chord motor columns requires cooperation with other Hox proteins. Can regulate PITX3 promoter activity; may promote midbrain identity in embryonic stem cell-derived dopamine neurons by regulating PITX3. Negatively regulates the differentiation of T follicular helper cells T(FH)s. Involved in maintenance of hair follicle stem cell quiescence; the function probably involves regulation of FGF18 (By similarity). Represses transcription of various pro-apoptotic genes and cooperates with NF-kappa B-signaling in promoting B-cell expansion by inhibition of caspase-dependent apoptosis (PubMed:25267198). Binds to CSF1R promoter elements and is involved in regulation of monocyte differentiation and macrophage functions; repression of CSF1R in monocytes seems to involve NCOR2 as corepressor (PubMed:15286807, PubMed:18799727, PubMed:18347093). Involved in endothelial cell proliferation, tube formation and migration indicative for a role in angiogenesis; the role in neovascularization seems to implicate suppression of SEMA5B (PubMed:24023716). Can negatively regulate androgen receptor signaling (PubMed:18640093). Acts as a transcriptional activator of the FBXL7 promoter; this activity is regulated by AURKA (PubMed:28218735). {ECO:0000250|UniProtKB:P58462, ECO:0000269|PubMed:15286807, ECO:0000269|PubMed:18640093, ECO:0000269|PubMed:18799727, ECO:0000269|PubMed:24023716, ECO:0000269|PubMed:25267198, ECO:0000269|PubMed:26647308, ECO:0000269|PubMed:28218735, ECO:0000305|PubMed:18347093, ECO:0000305|PubMed:24023716}.; FUNCTION: [Isoform 8]: Involved in transcriptional regulation in embryonic stem cells (ESCs). Stimulates expression of transcription factors that are required for pluripotency and decreases expression of differentiation-associated genes. Has distinct DNA-binding specifities as compared to the canonical form and preferentially binds DNA with the sequence 5'-CGATACAA-3' (or closely related sequences) (PubMed:21924763). Promotes ESC self-renewal and pluripotency (By similarity). {ECO:0000250|UniProtKB:P58462, ECO:0000269|PubMed:21924763}.

Q8IUR7

Main function of 5'-partner protein: FUNCTION: Component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1. {ECO:0000269|PubMed:29911972}.
Ensembl transtripts involved in fusion geneENST idsENST00000318779, ENST00000318789, 
ENST00000468577, ENST00000475937, 
ENST00000484350, ENST00000493089, 
ENST00000498215, ENST00000472382, 
ENST00000491238, 
ENST00000358441, 
ENST00000393058, ENST00000461822, 
ENST00000470821, ENST00000471453, 
ENST00000485396, ENST00000489213, 
ENST00000491704, ENST00000538260, 
ENST00000469044, ENST00000481646, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score34 X 30 X 13=132609 X 9 X 5=405
# samples 389
** MAII scorelog2(38/13260*10)=-5.124937546669
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/405*10)=-2.16992500144231
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: FOXP1 [Title/Abstract] AND ARMC8 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: FOXP1 [Title/Abstract] AND ARMC8 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)FOXP1(71247353)-ARMC8(137928659), # samples:1
Anticipated loss of major functional domain due to fusion event.FOXP1-ARMC8 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FOXP1-ARMC8 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FOXP1-ARMC8 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
FOXP1-ARMC8 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
FOXP1-ARMC8 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
FOXP1-ARMC8 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
FOXP1-ARMC8 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneFOXP1

GO:0002903

negative regulation of B cell apoptotic process

25267198

HgeneFOXP1

GO:0010629

negative regulation of gene expression

30111844

HgeneFOXP1

GO:0030316

osteoclast differentiation

18799727

HgeneFOXP1

GO:0032496

response to lipopolysaccharide

18799727

HgeneFOXP1

GO:0032680

regulation of tumor necrosis factor production

18799727

HgeneFOXP1

GO:0035926

chemokine (C-C motif) ligand 2 secretion

18799727

HgeneFOXP1

GO:0036035

osteoclast development

18799727

HgeneFOXP1

GO:0042116

macrophage activation

18799727

HgeneFOXP1

GO:0042117

monocyte activation

18799727

HgeneFOXP1

GO:0045655

regulation of monocyte differentiation

15286807

HgeneFOXP1

GO:0045892

negative regulation of transcription, DNA-templated

20950788

HgeneFOXP1

GO:0050706

regulation of interleukin-1 beta secretion

18799727

HgeneFOXP1

GO:0050727

regulation of inflammatory response

18799727

HgeneFOXP1

GO:0060766

negative regulation of androgen receptor signaling pathway

18640093

HgeneFOXP1

GO:1900424

regulation of defense response to bacterium

18799727

HgeneFOXP1

GO:1901256

regulation of macrophage colony-stimulating factor production

18799727

HgeneFOXP1

GO:2001182

regulation of interleukin-12 secretion

18799727



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:71247353/chr3:137928659)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across FOXP1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ARMC8 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000475937FOXP1chr371247353-ENST00000481646ARMC8chr3137928659+32456114312587718
ENST00000475937FOXP1chr371247353-ENST00000469044ARMC8chr3137928659+50856114312587718
ENST00000498215FOXP1chr371247353-ENST00000481646ARMC8chr3137928659+31375033232479718
ENST00000498215FOXP1chr371247353-ENST00000469044ARMC8chr3137928659+49775033232479718
ENST00000468577FOXP1chr371247353-ENST00000481646ARMC8chr3137928659+281418002156718
ENST00000468577FOXP1chr371247353-ENST00000469044ARMC8chr3137928659+465418002156718

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000475937ENST00000481646FOXP1chr371247353-ARMC8chr3137928659+0.0061225820.9938775
ENST00000475937ENST00000469044FOXP1chr371247353-ARMC8chr3137928659+0.0042430050.9957569
ENST00000498215ENST00000481646FOXP1chr371247353-ARMC8chr3137928659+0.0048146740.9951853
ENST00000498215ENST00000469044FOXP1chr371247353-ARMC8chr3137928659+0.0037510240.996249
ENST00000468577ENST00000481646FOXP1chr371247353-ARMC8chr3137928659+0.0064669630.993533
ENST00000468577ENST00000469044FOXP1chr371247353-ARMC8chr3137928659+0.004269860.9957301

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for FOXP1-ARMC8

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
FOXP1chr371247353ARMC8chr313792865918060AADLAHAQQQQQQEVTASSRHYVDRL
FOXP1chr371247353ARMC8chr313792865950360AADLAHAQQQQQQEVTASSRHYVDRL
FOXP1chr371247353ARMC8chr313792865961160AADLAHAQQQQQQEVTASSRHYVDRL

Top

Potential FusionNeoAntigen Information of FOXP1-ARMC8 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FOXP1-ARMC8_71247353_137928659.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FOXP1-ARMC8chr371247353chr3137928659180HLA-B48:01AQQQQQQEV0.81960.9262615
FOXP1-ARMC8chr371247353chr3137928659180HLA-A02:21AQQQQQQEV0.75810.8221615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B13:02AQQQQQQEV0.73180.9747615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B39:06QQQQQEVTA0.59950.9188817
FOXP1-ARMC8chr371247353chr3137928659180HLA-B50:01QQQQQEVTA0.56350.9726817
FOXP1-ARMC8chr371247353chr3137928659180HLA-B13:01AQQQQQQEV0.55480.9952615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B47:01AQQQQQQEV0.33490.6094615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B39:13AQQQQQQEV0.25110.9888615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B52:01AQQQQQQEV0.16280.9863615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:03QEVTASSRHY0.99940.94231222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:09QEVTASSRH0.98860.63961221
FOXP1-ARMC8chr371247353chr3137928659180HLA-A02:05AQQQQQQEV0.85720.6815615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B48:03AQQQQQQEV0.49570.8752615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B39:08AQQQQQQEV0.47030.9468615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:08AQQQQQQEV0.30620.7983615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:09QEVTASSRHY0.99950.51541222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B40:03QEVTASSRHY0.90040.5751222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B40:40AQQQQQQEV0.95130.574615
FOXP1-ARMC8chr371247353chr3137928659180HLA-A02:06AQQQQQQEV0.75810.8221615
FOXP1-ARMC8chr371247353chr3137928659180HLA-A02:14AQQQQQQEV0.75720.7904615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B15:73AQQQQQQEV0.73020.9775615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B50:05QQQQQEVTA0.56350.9726817
FOXP1-ARMC8chr371247353chr3137928659180HLA-B50:04QQQQQEVTA0.56350.9726817
FOXP1-ARMC8chr371247353chr3137928659180HLA-B15:30AQQQQQQEV0.53470.9661615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B40:12AQQQQQQEV0.49570.8752615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B40:21AQQQQQQEV0.46980.9212615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B40:49AQQQQQQEV0.42930.8608615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B39:02AQQQQQQEV0.33710.9887615
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:13QEVTASSRHY0.99940.94231222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:07QEVTASSRHY0.99940.94231222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B44:26QEVTASSRHY0.99940.94231222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B18:11QEVTASSRHY0.99320.89631222
FOXP1-ARMC8chr371247353chr3137928659180HLA-B15:53QEVTASSRHY0.9820.79751222

Top

Potential FusionNeoAntigen Information of FOXP1-ARMC8 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FOXP1-ARMC8_71247353_137928659.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1103QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1113QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1113QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1117QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1117QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1117QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1121QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1121QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1136QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1141QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1141QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1148QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1148QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1152QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1152QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1152QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1159QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1163QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1176QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1185QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1189QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1189QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1189QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1304QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1304QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1308QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1308QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1309QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1320QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1324QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1327QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1331QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1331QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1331QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1332QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1332QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1332QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1336QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1336QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1343QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1343QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1343QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1348QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1348QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1348QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1354QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1354QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1354QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1370QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1370QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1371QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1371QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1372QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1372QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1375QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1375QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1376QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1376QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1376QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1377QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1377QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1378QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1384QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1384QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1393QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1393QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1401QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1401QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1401QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1404QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1404QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1404QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1405QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1405QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1405QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1407QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1407QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1407QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1408QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1408QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1408QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1411QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1411QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1411QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1414QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1414QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1416QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1416QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1416QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1418QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1418QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1418QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1423QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1423QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1423QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1426QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1426QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1426QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1428QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1428QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1428QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1431QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1431QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1432QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1432QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1432QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1433QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1433QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1434QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1434QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1435QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1435QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1435QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1436QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1436QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1437QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1437QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1438QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1438QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1438QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1439QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1439QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1439QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1442QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1442QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1443QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1443QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1443QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1444QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1444QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1445QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1445QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1445QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1450QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1450QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1450QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1454QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1454QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1454QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1455QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1455QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1455QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1456QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1456QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1456QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1458QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1458QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1458QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1459QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1459QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1459QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1460QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1460QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1460QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1461QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1461QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1461QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1462QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1462QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1462QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1464QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1464QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1464QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1465QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1465QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1468QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1468QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1470QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1470QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1470QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1471QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1471QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1471QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1472QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1472QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1472QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1473QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1473QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1474QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1475QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1475QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1475QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1481QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1481QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1482QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1482QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1482QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1486QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1486QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1486QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1487QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1487QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1487QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1488QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1488QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1488QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1490QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1490QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1490QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1491QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1491QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1491QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1493QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1495QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1495QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1495QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1496QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1496QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1496QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1497QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1497QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1497QQQQEVTASSRHYVD924
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1499QQQEVTASSRHYVDR1025
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1499QQEVTASSRHYVDRL1126
FOXP1-ARMC8chr371247353chr3137928659180DRB1-1499QQQQEVTASSRHYVD924

Top

Fusion breakpoint peptide structures of FOXP1-ARMC8

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
528AQQQQQQEVTASSRFOXP1ARMC8chr371247353chr3137928659180

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of FOXP1-ARMC8

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN528AQQQQQQEVTASSR-7.9962-8.1096
HLA-B14:023BVN528AQQQQQQEVTASSR-5.70842-6.74372
HLA-B52:013W39528AQQQQQQEVTASSR-6.83737-6.95077
HLA-B52:013W39528AQQQQQQEVTASSR-4.4836-5.5189
HLA-A11:014UQ2528AQQQQQQEVTASSR-10.0067-10.1201
HLA-A11:014UQ2528AQQQQQQEVTASSR-9.03915-10.0745
HLA-A24:025HGA528AQQQQQQEVTASSR-6.56204-6.67544
HLA-A24:025HGA528AQQQQQQEVTASSR-5.42271-6.45801
HLA-B44:053DX8528AQQQQQQEVTASSR-7.85648-8.89178
HLA-B44:053DX8528AQQQQQQEVTASSR-5.3978-5.5112
HLA-A02:016TDR528AQQQQQQEVTASSR-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of FOXP1-ARMC8

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
FOXP1-ARMC8chr371247353chr31379286591221QEVTASSRHCAGGAAGTAACAGCTAGCAGTCGCCAC
FOXP1-ARMC8chr371247353chr31379286591222QEVTASSRHYCAGGAAGTAACAGCTAGCAGTCGCCACTAT
FOXP1-ARMC8chr371247353chr3137928659615AQQQQQQEVGCCCAGCAGCAGCAGCAACAGGAAGTA
FOXP1-ARMC8chr371247353chr3137928659817QQQQQEVTACAGCAGCAGCAACAGGAAGTAACAGCT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
FOXP1-ARMC8chr371247353chr31379286591025QQQEVTASSRHYVDRCAGCAACAGGAAGTAACAGCTAGCAGTCGCCACTATGTTGACAGG
FOXP1-ARMC8chr371247353chr31379286591126QQEVTASSRHYVDRLCAACAGGAAGTAACAGCTAGCAGTCGCCACTATGTTGACAGGCTA
FOXP1-ARMC8chr371247353chr3137928659924QQQQEVTASSRHYVDCAGCAGCAACAGGAAGTAACAGCTAGCAGTCGCCACTATGTTGAC

Top

Information of the samples that have these potential fusion neoantigens of FOXP1-ARMC8

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAFOXP1-ARMC8chr371247353ENST00000468577chr3137928659ENST00000469044TCGA-HN-A2NL-01A

Top

Potential target of CAR-T therapy development for FOXP1-ARMC8

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to FOXP1-ARMC8

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to FOXP1-ARMC8

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource